Candida albicans enhances iron uptake to maintain fluconazole resistance
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 16 of the 22 sources its claims cite were checked for support.
Abstract
A fluconazole-resistant Candida albicans strain shows enhanced intracellular iron accumulation, upregulated FRP1/FRE10/RBT5, increased ergosterol and ERG11/ERG9 expression, and deferasirox-fluconazole synergy.
Overview
CoChat Summary
TL;DR
Fluconazole-resistant (FR) *Candida albicans* accumulates more intracellular iron and upregulates iron-uptake genes, which supports iron-dependent increases in ergosterol biosynthesis and β-glucan exposure that help maintain fluconazole resistance. The FDA-approved iron chelator deferasirox (DFX) alone or with fluconazole kills FR lab and clinical strains, and low host iron reduces FR fungal burden during fluconazole treatment.
Key findings
- The lab-generated FR strain had fluconazole MIC >125 µg/mL versus 0.48 µg/mL for parent CAI4, but was twofold more sensitive to DFX (MIC 4.66 µg/mL vs 9.34 µg/mL). A sublethal DFX dose (2.33 µg/mL) synergized with 125 µg/mL fluconazole to completely inhibit FR growth.
- FR cells had significantly higher intracellular iron than CAI4 under both low and high iron (P < 0.05 and P < 0.0001, respectively), with upregulated expression of iron-uptake genes *FRP1*, *FRE10*, and *RBT5*, especially under high iron; the iron-utilization gene *BIO2* showed no difference.
- FR cells showed higher membrane ergosterol and expression of *ERG11* and *ERG9* under both iron conditions, plus higher β-glucan levels under high iron and greater β-glucan exposure under both conditions. Efflux was higher in FR (4.46-fold under high iron, 3.62-fold under low iron) but was iron-independent.
- In a murine oropharyngeal candidiasis model, fluconazole-treated mice with high iron had higher tongue fungal burden (log10 5.873) than low-iron mice (log10 5.454; P = 0.0107). DFX also synergized with fluconazole to kill FR clinical strains.
Methods
- *Strains and culture*: CAI4 + URA was the parent; the FR strain was generated by passaging CAI4 on fluconazole (128 µg/mL then 256 µg/mL) and maintained at 128 µg/mL. Deidentified clinical FR strains were received from Dr. Damian Krysan. Low-iron medium was YNB + 2% glucose; high-iron medium added 100 µM FeCl3·6H2O.
- *Assays*: fluconazole/DFX MIC and CFU viability; intracellular iron by colorimetric assay; gene expression by real-time PCR normalized to 18S rRNA; ergosterol quantification; β-glucan level/exposure by aniline blue and anti-β-1,3-glucan antibody; efflux by rhodamine 6G.
- *Mouse model*: 4- to 6-week-old female C57BL/6 mice were immunosuppressed with cortisone acetate, given iron-dextran (high iron) or DFX in drinking water (low iron), infected sublingually with FR, treated with fluconazole 1 mg/kg/day, and tongue CFU/g measured on day 5 (n = 10). Statistics used Mann-Whitney or one-way ANOVA, P < 0.05.
Limitations
- The paper does not include a dedicated limitations section. The authors state that the mechanism by which FR strains evolve sensitivity to iron chelation “requires further investigation.”
- Evident from the text: the main FR strain is lab-generated by passaging, so findings may not fully represent clinical FR isolates; clinical strains were tested only in vitro. Some experiments had limited replication (e.g., ergosterol and clinical-strain assays with two biological repeats; efflux shown as one representative experiment), and growth-rate data under high/low iron are reported as “data not shown.” The in vivo experiment used n = 10 mice per group.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
11 Valid · 0 Not valid · 4 Not checked · 33 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“β-glucans can act as a physical barrier, reducing the accessibility of fluconazole to its target sites in the cell membrane and limiting its effectiveness (12).”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > INTRODUCTION
What the sources say
- Supportedcites [12] Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D. 2007. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51: 510– 520. doi: 10.1128/AAC.01056-06 17130296 PMC1797745 source
The Discussion (page unavailable) suggests that β-1,3 glucan may physically interact with antifungals and inhibit their penetration to the site of action. The Results (page unavailable) also show that added β-1,3 glucan reduced fluconazole activity. The paper presents the barrier mechanism as a possibility, consistent with the claim’s “can act” wording, rather than as proven. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In line with the previous findings (30), this suggests that elevated iron levels are redistributed for the production of very specific iron-related proteins.”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > DISCUSSION
What the sources say
- Supportedcites [30] Hunsaker EW, Franz KJ. 2019. Candida albicans reprioritizes metal handling during fluconazole stress. Metallomics 11: 2020– 2032. doi: 10.1039/c9mt00228f 31709426 PMC6927248 source
The Discussion proposes that C. albicans mobilizes iron to sites of iron-protein synthesis and increases iron uptake to meet that need. It also says iron is likely redistributed to iron–sulfur clusters and hemes during fluconazole treatment, supporting the citing sentence’s hedged interpretation. (LLM, conf=0.90)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C. albicans reprioritizes metal handling during fluconazole stress, including that for iron (30).”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > DISCUSSION
What the sources say
- Supportedcites [30] Hunsaker EW, Franz KJ. 2019. Candida albicans reprioritizes metal handling during fluconazole stress. Metallomics 11: 2020– 2032. doi: 10.1039/c9mt00228f 31709426 PMC6927248 source
The Discussion reports that fluconazole-treated C. albicans retains more iron and appears to prioritize iron use over storage. The Results section on heme synthesis also reports changes in total and labile iron during treatment, supporting the claim that iron handling is reprioritized. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“along with an increase in the expression of ergosterol biosynthesis genes (ERG11 and ERG9), compared to CAI4, under both low and high iron.”
- Also stated in: § Accumulated intracellular iron enhances membrane sterols and cell wall β-glucan levels and exposure in FR C. albicans · plain
“Membrane ergosterol levels and ERG9 and ERG11 expression were higher in the FR strain, compared to CAI4 (Fig. 3A and B), under both iron conditions.”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Accumulated intracellular iron enhances membrane sterols and cell wall β-glucan levels and exposure in FR C. albicans · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CAI4 strain was susceptible to fluconazole, with an MIC of 0.48 µg/mL”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > RESULTS > Iron chelation alone or in combination with fluconazole is an effective antifungal strategy against FR C. albicans
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
19 more claims
Create a free account to see all 48 claims and every source verdict.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > DISCUSSION
“We previously showed that high iron signals increase β-glucan levels and exposure (24), and our present study shows the accumulation of iron in the FR strain had the same effect (Fig. 3B).”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > RESULTS > Accumulated intracellular iron enhances membrane sterols and cell wall β-glucan levels and exposure in FR C. albicans
“(C) β-glucan level and (D) β-glucan exposure were measured by aniline blue dye and anti-β-1,3-glucan antibody in high iron and low iron, respectively.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > DISCUSSION
“Increased expression of ergosterol biosynthesis genes (Fig. 3A) that is needed for fluconazole resistance suggests that lanosterol 14α-demethylase (Cyp51), an iron-requiring heme protein (31) involved in ergosterol biosynthesis, is upregulated (32).”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > RESULTS > Accumulated intracellular iron enhances membrane sterols and cell wall β-glucan levels and exposure in FR C. albicans
“(A) Percent ergosterol levels of CAI4 and FR strains were measured in high and low iron. The results of two independent biological repeats are represented as means ± SEM. (B) Gene expression study of ergosterol biosynthesis pathway-related genes was assessed in CAI4 and FR strains under high and low iron by real-time PCR analysis.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > MATERIALS AND METHODS > Antifungal susceptibility assay
“For CFU study, FR and CAI4 strains were grown overnight in YNB medium with or without fluconazole respectively. The next day, 50 µL of culture (from 1 × 104 cell suspension) was plated on LIM-agar plates containing 128 µg/mL fluconazole alone or in combination with 2.33 µg/mL DFX”
§ Candida albicans enhances iron uptake to maintain fluconazole resistance > RESULTS > Iron chelation alone or in combination with fluconazole is an effective antifungal strategy against FR C. albicans
“(B) Pictorial representation of the CFU assay for CAI4 and FR strains under different conditions—control (YNB media only), fluconazole (125 µg/mL), sublethal deferasirox (DFX; 2.33 µg/ml), and fluconazole (125 µg/mL) + sublethal DFX (2.33 µg/mL).”
Citations
Cites
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642
Fluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542
Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385
Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology · doi:10.1099/00221287-145-10-2701 · Cited by 382 · cited 1×
“3A) that is needed for fluconazole resistance suggests that lanosterol 14α-demethylase (Cyp51), an iron-requiring heme protein (31) involved in ergosterol biosynthesis, is upregulated (32).”
A High-Affinity Iron Permease Essential for Candida albicans Virulence
Ramanan, N., & Wang, Y. (2000) · Science · doi:10.1126/science.288.5468.1062 · Cited by 336
An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1
Selmecki, A., Gerami‐Nejad, M., Paulson, C., Forche, A., & Berman, J. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06176.x · Cited by 325
Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans
Caza, M., & Kronstad, J. W. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00080 · Cited by 306 · cited 1×
“Iron is an indispensable micronutrient essential for the pathogenesis and survival of fungal pathogens (17).”
Cited by
Machine Learning-Guided Design of High-Performance Antifungal Polymers against Candida albicans
Roh, J., Huang, K.-T., Choudhury, A., Quan, T., Huang, C., Kumar, P. V., & Boyer, C. A. (2025) · ACS Polymers Au · doi:10.1021/acspolymersau.5c00057 · Cited by 17
Kim, D., Shin, J., Cho, Y., Kronstad, J. W., & Jung, W. H. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2504.04007 · Cited by 4
“Similarly, in another study, iron uptake and homeostasis contributed to azole susceptibility in Candida albicans [20].”
Tóth, Z., Farkas, B., Majoros, L., Jakab, Á., Borman, A. M., Varga, I., Tóth, P., & Kovács, R. (2025) · Medical Mycology · doi:10.1093/mmy/myaf116 · Cited by 3
“18 , 19 Moreover, previous studies have shown that increased iron availability may promote Candida persistence and pathogenicity, 11 , 20 , 21 supporting the rationale for therapeutic iron restriction.”
Prochelators modulate azole activity against Candida albicans in a metal-dependent manner
Merriman, M. A., Denning-Jannace, C. A., Hurtado, A. B., Vaccaro, F. A., Sung, Y., Tomat, E., & Franz, K. J. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00073h · Cited by 2
Hsu, L.-H., Chou, Y. Y., Shen, T., Wieczorek, D., & Chen, Y. (2025) · Virulence · doi:10.1080/21505594.2025.2609407 · Cited by 1
Metadata
- Authors
- Sharma, R., Nahar, A., & Puri, S.
- Affiliations
- Temple University (US)
- Corresponding author
- Puri, Sumant
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2025-03-11
- Volume
- 93
- Issue
- 3
- Pages
- e0000225-e0000225
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC11895461
- OpenAlex
- W4407239752
- Cited by
- 8
- References
- 39
- Citations by year
- 2026: 4 · 2025: 4
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Infection and Immunity (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | NIH | National Institute of Dental and Craniofacial Research (R01DE030130)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, fluconazole resistance, iron absorption, deferasirox, iron chelation, ergosterol biosynthesis, ERG11, drug synergy, antifungal resistance, fungal virulence, β-glucan, mouse infection model
- MeSH terms
- Deferasirox, Animals, Antifungal Agents, Candida albicans, Candidiasis, Ergosterol, Iron, Microbial Sensitivity Tests, Fluconazole, Drug Resistance, Fungal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Candida albicans enhances iron uptake to maintain fluconazole resistance. https://app.cochat.ai/papers/10.1128/iai.00002-25
- The paper
- Sharma, R., Nahar, A., & Puri, S. (2025). Candida albicans enhances iron uptake to maintain fluconazole resistance. Infection and Immunity. https://doi.org/10.1128/iai.00002-25
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.